Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07843849 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Corticosteroid for Diabetic Macular Edema (DME) Study

Name: Corticosteroid for Diabetic Macular Edema (DME) Study — clinical trial record (NCT07843849)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorVanderbilt University Medical Center

Started2026-04-07

View on ClinicalTrials.gov ↗

Vanderbilt University Medical Center

320 trials monitored

See 25 trials at risk

Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory cytokines before and after treatment of DME with intravitreal corticosteroid injections. We want to continue the study for one more year as our initial data analysis from the original INSPIRE study shows a possible direct correlation between aqueous biomarkers and DME. We propose treating the DME with corticosteroid to assess the effect upon the intraocular cytokines with inflammation is suppressed.

Trial Details

NCT Number	NCT07843849
Lead Sponsor	Vanderbilt University Medical Center
Conditions	Diabetic Macular Edema (DME), Diabetic Retinopathy
Enrollment	20 participants
Start Date	2026-04-07
Primary Completion	2028-03 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2026-09-28